Objective: Obesity is central in the development of insulin resistance. However, the underlying mechanisms still need elucidation. Dysregulated microRNAs (miRNAs; post-transcriptional regulators) in adipose tissue may present an important link. Methods: The miRNA expression in subcutaneous adipose tissue from 19 individuals with severe obesity (10 women and 9 men) before and after a 15-week weight loss intervention was studied using genomewide microarray analysis. The microarray results were validated with RT-qPCR, and pathway enrichment analysis of in silico predicted targets was performed to elucidate the biological consequences of the miRNA dysregulation. Lastly, the messenger RNA (mRNA) and/or protein expression of multiple predicted targets as well as several proteins involved in lipolysis were investigated. Results: The intervention led to upregulation of miR-29a-3p and miR-29a-5p and downregulation of miR20b-5p. The mRNA and protein expression of predicted targets was not significantly affected by the intervention. However, negative correlations between miR-20b-5p and the protein levels of its predicted target, acyl-CoA synthetase long-chain family member 1, were observed. Several other miRNA-target relationships correlated negatively, indicating possible miRNA regulation, including miR-29a-3p and lipoprotein lipase mRNA levels. Proteins involved in lipolysis were not affected by the intervention. Conclusions: Weight loss influenced several miRNAs, some of which were negatively correlated with predicted targets. These dysregulated miRNAs may affect adipocytokine signaling and forkhead box protein O signaling.
Introduction
Insulin resistance, type 2 diabetes, and cardiovascular disease are the major adverse outcomes of obesity (1), which has reached pandemic levels. Thus, there is a need for therapeutic strategies to combat obesity and comorbidities. The post-transcriptional regulators, microRNAs (miRNAs), have the potential to cause cleavage or translational repression of their target messenger RNAs (mRNAs) (2) . In recent years, miRNAs have emerged as important gene regulators in adipocyte differentiation and adipogenesis (3) . It has been shown in humans that extreme weight loss impacts adipose tissue (AT) cell size, insulin sensitivity, and DNA methylation (4, 5) . Thus, aberrant epigenetic regulation, such as dysregulated miRNAs, may lead to pathogenic processes, such as increased fasting plasma glucose, insulin, and triglyceride levels (6, 7) . Weight loss interventions represent an excellent model for the study of the molecular mechanisms underlying the pathophysiology of obesity. However, studies investigating the human AT miRNA profiles in obesity have mainly been cross-sectional comparisons between individuals with or without obesity (8, 9) or have correlated body mass index (BMI) with miRNA expression in individuals of varying BMI (10, 11) . A paired study compared the miRNA expression of omental AT with that of subcutaneous AT (SAT) (12) . To our knowledge, there are no longitudinal studies that have investigated the global miRNA profile of human SAT during weight loss induced by diet and exercise. Furthermore, the previous findings of dysregulated miRNAs in obesity applying cross-sectional designs are characterized by great inconsistency (13) , and there is a need to elucidate this topic.
Here we studied the effect of a 15-week weight loss intervention in individuals with severe obesity. To identify miRNAs influenced by the intervention, we performed genome-wide miRNA analysis by microarray. We validated the miRNA candidates by reversetranscription quantitative real-time polymerase chain reaction (RTqPCR). To elucidate post-transcriptional regulation by these miRNAs, we analyzed the in silico predicted targets of the miRNAs by pathway enrichment analysis. Subsequently, we performed RTqPCR analysis and Western blot analysis of selected targets. Additionally, we examined several enzymes and regulators of lipolysis by Western blot analysis to gain insight into the dynamics of lipolysis in SAT during weight loss.
Methods

Study design
The study was approved by the Ethical Committee of Copenhagen (ref. no. KF 01-220/03), and we followed the guidelines of the Declaration of Helsinki. All subjects gave written informed consent before study participation. The samples included here are part of a larger study that examined metabolism and inflammation in adipose and muscle tissue during weight loss (14) (15) (16) . In total, 19 individuals with severe obesity (10 women and 9 men) were recruited from a lifestyle center, where they underwent a 15-week weight loss intervention including moderate daily exercise and a hypocaloric diet. The weight loss program has previously been described in detail (14) ; at baseline and post intervention, anthropometrics and blood pressure were measured and blood samples and SAT biopsies were collected. Furthermore, plasma levels of cholesterol, triglycerides, and hemoglobin A 1c , body composition, maximal oxygen consumption, and oral glucose tolerance were assessed at baseline and post intervention. Table 1 presents the clinical characteristics of the participants.
Biopsies and RNA purification SAT biopsies were sampled at baseline and after the 15-week intervention, and the procedure has been described in detail previously (14) . Total RNA was extracted from approximately 350 mg of SAT using TRIzolV R (Invitrogen, Carlsbad, CA). Purity and quantity of RNA were assessed with the NanoDrop TM spectrophotometer (Thermo Fisher Scientific, Boston, MA).
Locked nucleic acid microarrays
Microarrays were performed on 38 samples (Exiqon, Vedbaek, Denmark). A detailed description of the labeling and hybridization method is available in the Supporting Information. All data analyses, including quality control, were performed in R. Annotation of the arrays were updated to miRBase version 18 (17) . The quantified signals were background corrected and normalized using LOESS in marray (18) and linear models for microarray analysis (LIMMA) (19, 20) . Fourteen arrays did not pass quality control. Therefore, the downstream analysis was performed based on 24 arrays. Data have been made publicly available at the National Center for Biotechnology Information Gene Expression Omnibus database with the accession number GSE87103.
Validation of miRNA expression levels by RT-qPCR
Selected miRNAs were validated in all 38 samples with the RTqPCR method miRCURY LNA TM Universal RT microRNA PCR (Exiqon) according to the manual. Universal RT is followed by qPCR amplification with locked nucleic acid (LNA)-enhanced primers using ExiLENT SYBR V R Green Master Mix. We performed triplicate RT, and qPCR amplification was performed in single reactions on the Applied Biosystems 7900HT Fast Real-Time PCR System (Applied Biosystems, Carlsbad, CA). We used the following miRNA assays from Exiqon: miR-20b-5p, miR-29-3p, miR-29-5p, miR-32-5p, miR-125b-5p, miR-144-5p, miR-331-3p, miR365b-5p, miR-454-3p, miR-590-5p, and miR-769-5p. To determine the relative abundance of each miRNA, we applied the 2 -DDCq method (21) and used miR-331-3p as an endogenous control, which has been shown to be a miRNA candidate endogenous control in AT (22) . The stability of miR-331-3p in this data set was confirmed in the microarray data and also in the RT-qPCR data using the NormFinder algorithm (23) in comparison with two other endogenous control candidates, miR-125b-5p and miR-365b-5p. The data were normalized to baseline values. In silico target prediction and pathway enrichment analysis
We used TargetScanHuman release 6.2 (24) to identify potential miRNA targets. We filtered the vast list of potential targets by employing the TISSUES database (25) ; genes expressed in AT with a confidence score of 4 or higher and genes in the adipocytokine signaling pathway, as defined by the Kyoto Encyclopedia of Genes and Genomes (KEGG), were included. Pathway enrichment analysis of the filtered targets was performed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) version 6.8 (26, 27) , and the background was defined according to the filter applied. We considered pathways with a false discovery rate (FDR) of less than 0.05 as significantly enriched.
Investigation of predicted miRNA target genes by RT-qPCR
Based on the target prediction analyses, we chose a subset of mRNAs for testing by RT-qPCR. We performed triplicate RT of 125 ng total RNA with poly-dT primer in 20 ml with the Omniscript RT kit (Qiagen, Valencia, CA) according to the user manual. We amplified 0.1 ml cDNA in single reactions with the QuantiTect SYBR V R Green PCR Master Mix (Qiagen) and 100 nM of each primer. A detailed description of primer sequences is available in the Supporting Information. The 7900HT RT-qPCR System was used to measure mRNA expression levels. We applied the 2 -DDCq method to determine the relative abundance of each mRNA. As endogenous control mRNA, we used phosphoglycerate kinase 1 (PGK1), which has been shown to be a candidate endogenous control gene in AT (22) . We tested three other endogenous control candidates-low-density lipoprotein receptor-related protein 10, peptidylprolyl isomerase A, and ribosomal protein lateral stalk subunit P0-to validate the stability of PGK1 in the RT-qPCR data. In addition, the NormFinder algorithm was used to calculate the most stable endogenous control, which confirmed PGK1 as the most suitable endogenous control for this data set. The data were normalized to baseline average values.
Western blot analysis of predicted miRNA targets and enzymes and regulators of lipolysis
A limited number of adipose biopsies were available for Western blot analysis, resulting in 20 paired samples (n 5 10 at baseline and n 5 10 post intervention). A detailed description of the preparation of tissue homogenates and Western blot analysis procedure is available in the Supporting Information.
Statistics
Clinical characteristics, RT-qPCR, and Western blot analysis. We performed statistical analyses of the clinical characteristics on normally distributed data using a paired t test. If the data were not normally distributed, the nonparametric paired Wilcoxon signed rank test was used as indicated. Statistical analyses of RT-qPCR data were carried out on DDCq values using a paired t test. We performed a paired t test on the protein expression levels. All data are presented as mean 6 SE. The level of significance was set to P < 0.05. The Bonferroni correction was applied to the mRNA analysis and Western blot analysis to adjust for multiple comparisons. We performed the analyses in SigmaPlot (Systat Software, San Jose, CA).
Microarray. The statistical significance of differential expression of each miRNA was assessed using LIMMA with gender as a covariate. Only mature miRNAs that were detected in at least one of two human adipose small RNA sequencing studies using the Illumina Genome Analyzer II platform (6,28) were considered. Notably, the study overlap was 80%. To find miRNAs that were altered by the intervention, individual IDs were added as a factor in order to get a paired design. P values were adjusted with Benjamini-Hochberg's FDR (29) . The level of significance for differential expression was set to FDR 0.05.
Correlation analyses. We performed Pearson correlation analyses between microarray data (log2 expression values) and RT-qPCR data (-DDCq values) and also between RT-qPCR data and protein data (protein content) in GraphPad Prism version 6.01 (GraphPad Software, La Jolla, CA).
Results
Microarray
The microarray analysis revealed nine miRNAs in SAT that were either upregulated (miR-29a-3p, miR-29a-5p, miR-196a-3p, and miR-769-5p) or downregulated (miR-20b-5p, miR-32-5p, miR-144-5p, miR-454-3p, and miR-590-5p) after the intervention ( Table 2 ).
Validation of miRNAs by RT-qPCR
Of the nine differentially expressed miRNAs, eight assays were commercially available, and, thus, we validated all except miR196a-3p with RT-qPCR. Generally, the correlation between the microarray data and the RT-qPCR data was good (0.53 < r < 0.85; P < 0.008), although miR-32-5p (r 5 0.32; P 5 0.13) and miR-590-5p (r 5 0.13; P 5 0.08) did not correlate well (Supporting Information Figure S1 ). Two of the upregulated miRNAs, miR-29a-3p and miR-29a-5p, and one of the downregulated miRNAs, miR-20b-5p, were confirmed to be differentially expressed between baseline and post intervention ( Figure 1A ). Moreover, we observed a borderline significant downregulation of miR-454-3p (P 5 0.065).
Target prediction and pathway enrichment analysis
We used TargetScanHuman to identify predicted target mRNAs for the differentially expressed miRNAs. We included predicted targets for miR-29a-3p, miR-20b-5p, and miR-454-3p, although the latter miRNA was only borderline significant in the RT-qPCR validation data. Furthermore, there were no predicted targets for miR-29a-5p in TargetScanHuman release 6.2. We used the TISSUES database to filter the targets according to relevance. We included genes that are expressed in AT with a confidence score of 4 or higher and genes in the KEGG adipocytokine signaling pathway. Sixty-eight putative miRNA-mRNA relationships were filtered from 3,159; when corrected for replicate targets, the list was shortened to 56 genes (Supporting Information Table S1 ). With the online tool DAVID, we performed pathway enrichment analysis of these 56 genes, and adipocytokine signaling pathway and forkhead box protein O (FOXO) signaling pathway had significant enrichment (FDR < 0.05). Several other pathways involved in metabolism were enriched, although not significantly (Table 3) .
Investigation of predicted miRNA targets
We selected and tested 10 of the 56 predicted target mRNAs with RT-qPCR in SAT from all 19 subjects in order to examine the effect of the intervention on the mRNA expression levels. After correcting for multiple testing, none of the mRNA expression levels of the selected predicted targets was significantly changed post intervention ( Figure 1B) . Eight additional mRNAs were tested but did not perform well, probably due to either low expression or defective primer assays. All the selected mRNAs are shown in Table 4 . Six of the predicted miRNA targets were also examined on the protein level in a subgroup of individuals (n 5 10) by Western blot analysis: acylCoA synthetase long-chain family member 1 (ACSL1), acyl-CoA synthetase long-chain family member 4 (ACSL4), lipoprotein lipase (LPL), monoglyceride lipase (MGLL), solute carrier family 2 member 4 (SLC2A4), and signal transducer and activator of transcription 3 (STAT3). The intervention did not lead to significant differential expression at the protein levels of these predicted targets in SAT of these subjects ( Figure 1C ).
Correlation analyses between the miRNAs and their predicted targets revealed several interesting relationships (Figure 2 ). The protein levels of ACSL1 correlated negatively with miR-454-3p, as did ACSL4 (Figure 2A-2B) . Moreover, miR-20b-5p was negatively There were no significant changes in the mRNA expression levels of any of the predicted targets after correction for multiple comparisons. Data shown as a fold change normalized to baseline average values and expressed as mean 6 SE. (C) Western blot analysis of predicted targets of miR-20b-5p, miR-29a-3p, and miR-454-3p between baseline (n 5 10) and post intervention (n 5 10); ACSL1, ACSL4, LPL, MGLL, SLC2A4, and STAT3. There were no significant changes in protein expression levels of any of the predicted targets. Data shown as protein content in arbitrary units (AU) normalized to baseline average values and expressed as mean 6 SE. Abbreviations: ACSL1 (acyl-CoA synthetase long-chain family member 1), ACSL4 (acyl-CoA synthetase long-chain family member 4), AKT3 (AKT serine/ threonine kinase 3), IGF1 (insulin-like growth factor 1), IRS1 (insulin receptor substrate 1), LEP (leptin), LPL (lipoprotein lipase), MGLL (monoglyceride lipase), miRNA (microRNA), PPARG (peroxisome proliferator activated receptor gamma), PPARGC1A (PPARG coactivator 1 alpha), RT-qPCR (reverse-transcription quantitative real-time polymerase chain reaction), SLC2A4 (solute carrier family 2 member 4), STAT3 (signal transducer and activator of transcription 3).
Original Article
Obesity The last column indicates which differentially expressed miRNAs are predicted regulators of the respective genes. miRNAs (microRNAs), RT-qPCR (reverse-transcription quantitative real-time polymerase chain reaction), SAT (subcutaneous adipose tissue).
Obesity
Influence of Weight Loss on Human Adipose miRNAs Kristensen et al. correlated with ACSL4 protein levels ( Figure 2C ). The mRNA levels of LPL and miR-29a-3p correlated negatively ( Figure 2D ), but this was not reflected on the protein level (data not shown). MGLL, SLC2A4, and STAT3 protein levels were all negatively correlated with miR-20b-5p ( Figure 2E-2G) . Furthermore, STAT3 was negatively correlated with miR-454-3p ( Figure 2H ).
Investigation of enzymes and regulators of lipolysis
We performed Western blot analysis of several enzymes and regulators of lipolysis: abhydrolase domain containing 5 (ABHD5), angiopoietin-like 4 (ANGPTL4), cell death-inducing DFFA-like effector a (CIDEA), cell death-inducing DFFA-like effector c (CIDEC), G0/G1 switch (G0S2), perilipin 1 (PLIN1), and patatin-like phospholipase domain containing 2 (PNPLA2). Figure 3 shows the specific protein levels relative to total protein. None of the proteins was significantly regulated by the intervention.
Discussion
In the present study, we revealed two major findings. First, a 15-week weight loss intervention led to upregulation of miR-29a-3p and miR-29a-5p and downregulation of miR-20b-5p. Second, the mRNA and/or protein levels of several predicted targets of the differentially expressed miRNAs were unaffected by the intervention. However, an inverse correlation was seen in several of the predicted miRNA-target relationships, indicating a plausible regulatory association. We investigated several enzymes and regulators of lipolysis and none was significantly regulated by the intervention.
We used a genome-wide approach to identify differentially expressed miRNAs and subsequently validated the microarray results by RT-qPCR in the full sample set, thereby confirming upregulation of miR-29a-3p and miR-29a-5p and downregulation of miR-20b-5p. Although a significant difference was not observed for all the miRNAs investigated by RT-qPCR, the data correlated well with the array data. To gain further insight into the cellular consequences of these miRNA changes, we explored the predicted targets of these three miRNAs, including miR-454-3p, which was borderline downregulated in the RT-qPCR data. In silico target prediction revealed a long list of possible miRNA-mRNA relationships. Fewer than 2% of these predicted target genes are expressed in AT at a high confidence. Therefore, we reduced the number of genes accordingly before performing pathway enrichment analysis. As expected, adipocytokine signaling was the most enriched KEGG pathway, but, additionally, FOXO signaling pathway was significantly enriched. Therefore, these miRNAs potentially play a role in the regulation of metabolic processes in AT. We investigated a subset of the target genes on the mRNA and/or protein level, but none of the predicted targets was significantly affected by the intervention on the mRNA or protein levels. SLC2A4 (often referred to as "GLUT4") is the main insulin-mediated glucose transporter responsible for the uptake of glucose into adipocytes, skeletal muscle, and the heart in response to insulin. SLC2A4 has been shown to be expressed at lower levels in AT in obesity and type 2 diabetes (30). We did not observe any significant changes in SLC2A4 mRNA or protein levels. However, we did observe an inverse correlation between SLC2A4 protein levels and miR-20b-5p levels, indicating a derepression of SLC2A4.
In the present study, we observed an upregulation in the levels of both the "sense" and "anti-sense" strands of miR-29a (miR-29a-3p and miR-29a-5p). The version of TargetScan employed here (release 6.2) only revealed predicted targets for the "3p"-strand, miR-29a-3p, and none for miR-29a-5p. One of these targets, LPL, is an important enzyme in lipid metabolism (31) , and we observed a significant inverse relationship between mRNA levels and miR29a-3p. The mRNA and protein levels of LPL were not significantly changed in this study, but previous studies performed in mice have revealed repression by miR-29a on LPL mRNA levels in adipocytes (32) and on both mRNA and protein levels of LPL in the liver (33) . Therefore, we present for the first time an association in human tissue. Accumulating data are pointing to the miR-29 family as a highly relevant miRNA in the study of weight loss and metabolic disease. We have recently found that another member of the miR-29 family, miR-29b-3p, is increased after gastric bypass surgery in skeletal muscle (unpublished data), and miR-29a and miR-29c are increased in skeletal muscle from patients with type 2 diabetes (34).
In the adipocytes, ACSL1 and ACSL4 catalyze the formation of acylCoAs that are used for b-oxidation and thereby contribute to fatty acid metabolism (35) . Both proteins are predicted targets of miR-454-3p, and ACSL4 is also a predicted target of miR-20b-5p. Both miRNAs were downregulated by the intervention (although miR-454-3p was borderline significant), and there was an inverse correlation between protein levels and miRNAs, indicating a de-repression of ACSL1 and ACSL4. However, the increase in the protein levels of ACSL1 and ACSL4 in the present study was not significant.
The transcription factor STAT3 is important for energy homeostasis in leptin signaling (36) . STAT3 is a predicted target of miR-20b-5p 
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and miR-454-3p, and we did observe an inverse correlation between STAT3 protein levels and both miR-20b-5p and miR-454-3p. Although we did not observe a significant derepression of STAT3, it is intriguing that two miRNAs may work together in the regulation of genes (ACSL4 and STAT3) that play a role in energy homeostasis and metabolism. This may be a way of fine-tuning gene regulation (37) and adds to the significance of and could explain the modest miRNA changes seen in the present study.
Previous studies of human miRNA profiles in SAT have observed correlations with BMI and miRNAs; miR-21 has been found to correlate positively with BMI (10), and miR-221, miR-193a-3p, and miR193b-5p have been found to correlate with BMI in Pima Indians (11) . Other studies have compared individuals with or without obesity and found overexpression of mir-519d in obesity (9) and multiple miRNAs differentially dysregulated in obesity (8) . Overall, there is much discrepancy between previous reports (13), and we did not observe differential expression of any of the previously reported miRNAs. This underlines the importance of stratified designs and standardized protocols. Many of the previous studies have grouped individuals with very wide BMI ranges, and the divisions between groups were narrow. Another variation in results may arise from differences in choices of endogenous controls for RT-qPCR. However, the present intervention study is the first to report SAT miRNAs influenced by diet-and exercise-induced weight loss in a paired design.
Lipid droplets in adipocytes contain triglycerides encapsulated by phospholipids and many proteins essential for lipolysis, a process that has been reviewed in detail (38) . How obesity and BMI influence the status of the different enzymes and regulators in the lipid droplet is somewhat controversial. This intervention did not alter any of the analyzed enzymes and regulators of lipolysis significantly. It is possible that changes are happening at an earlier stage of the weight loss. Recent data in brown AT suggest that the cell attempts to conserve energy stores during weight loss (39) , and this may explain why we did not observe any significant changes in proteins that regulate lipolysis 15 weeks into a weight loss program.
Limitations
We observed several inverse correlations of miRNAs and their target mRNA or protein levels. However, this study does not allow for direct evidence of repression by miRNAs on their targets, and these mechanisms would have to be investigated further to gain more insight into these potential miRNA-target relationships. Cell culture experiments with overexpression or knockdown of miRNAs would enable us to elucidate this. Additionally, the experimental setup does not allow a distinction between the different cell types within AT. Thus, the combined weight loss-induced changes of both adipocytes and inflammatory cells could in part be responsible for the changes observed in the miRNAs. This point is supported by our previous findings that weight loss in these individuals led to an attenuated chronic low-grade inflammation in the AT samples (14) . However, we find that the use of whole AT fragments reflects changes in in vivo physiology more than the use of isolated adipocytes.
Conclusions
Here we show that weight loss affects the expression of three miRNAs in SAT. Investigation of the mRNA and protein levels of several predicted target genes revealed some interesting miRNAtarget associations. Pathway enrichment analysis of predicted miRNA targets pointed to the involvement of FOXO signaling pathways. In future studies of insulin resistance and impaired lipid metabolism in AT, these miRNAs are intriguing candidates.O
